143 related articles for article (PubMed ID: 10079003)
21. Recombinant saphenous vein 5-HT1B receptors of the rabbit: comparative pharmacology with human 5-HT1B receptors.
Wurch T; Palmier C; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1997 Jan; 120(1):153-9. PubMed ID: 9117091
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the human basilar artery contractile response to 5-HT and triptans.
Silva SA; Marques FB; Fontes Ribeiro CA
Fundam Clin Pharmacol; 2007 Jun; 21(3):265-72. PubMed ID: 17521295
[TBL] [Abstract][Full Text] [Related]
23. Influence of the endothelium and nitric oxide on the contractile responses evoked by 5-HT1D receptor agonists in the rabbit isolated saphenous vein.
Valentin JP; Bonnafous R; John GW
Br J Pharmacol; 1996 Sep; 119(1):35-42. PubMed ID: 8872354
[TBL] [Abstract][Full Text] [Related]
24. Amplification of sumatriptan-induced contraction in rabbit saphenous vein but not in basilar artery.
Bhattacharya A; Schenck KW; Cohen ML
Am J Physiol Heart Circ Physiol; 2003 Feb; 284(2):H719-26. PubMed ID: 12424094
[TBL] [Abstract][Full Text] [Related]
25. GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein.
Humphrey PP; Feniuk W; Perren MJ; Connor HE; Oxford AW; Coates LH; Butina D
Br J Pharmacol; 1988 Aug; 94(4):1123-32. PubMed ID: 2850055
[TBL] [Abstract][Full Text] [Related]
26. Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist.
Connor HE; Feniuk W; Humphrey PP
Br J Pharmacol; 1989 Feb; 96(2):379-87. PubMed ID: 2538191
[TBL] [Abstract][Full Text] [Related]
27. Contractile effects of 8-hydroxy-2-(di-n-propylamino)tetralin and flesinoxan in human isolated basilar artery.
Parsons AA; Motevalian M; Whalley ET
Eur J Pharmacol; 1991 Sep; 202(1):17-23. PubMed ID: 1664803
[TBL] [Abstract][Full Text] [Related]
28. Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery.
Jähnichen S; Radtke OA; Pertz HH
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):54-63. PubMed ID: 15185063
[TBL] [Abstract][Full Text] [Related]
29. 5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants.
Matzen L; van Amsterdam C; Rautenberg W; Greiner HE; Harting J; Seyfried CA; Böttcher H
J Med Chem; 2000 Mar; 43(6):1149-57. PubMed ID: 10737747
[TBL] [Abstract][Full Text] [Related]
30. In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine(1B) autoreceptor antagonist.
Ahlgren C; Eriksson A; Tellefors P; Ross SB; Stenfors C; Malmberg A
Eur J Pharmacol; 2004 Sep; 499(1-2):67-75. PubMed ID: 15363952
[TBL] [Abstract][Full Text] [Related]
31. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.
Cohen ML; Schenck KW; Hemrick-Luecke SH
J Pharmacol Exp Ther; 1999 Sep; 290(3):1195-201. PubMed ID: 10454495
[TBL] [Abstract][Full Text] [Related]
32. Influence of the endothelium on contractile effects of 5-hydroxytryptamine and selective 5-HT agonists in canine basilar artery.
Connor HE; Feniuk W
Br J Pharmacol; 1989 Jan; 96(1):170-8. PubMed ID: 2538180
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous measurement of [3H]noradrenaline release and neurogenic contraction under identical conditions, to determine the prejunctional inhibitory effects of SKF 99101H and BRL 56905 in dog saphenous vein.
Medhurst AD; Brown AM; Kaumann AJ; Parsons AA
Naunyn Schmiedebergs Arch Pharmacol; 1997 Apr; 355(4):475-82. PubMed ID: 9109364
[TBL] [Abstract][Full Text] [Related]
34. Serotonin-induced contraction in canine coronary artery and saphenous vein: role of a 5-HT1D-like receptor.
Cushing DJ; Baez M; Kursar JD; Schenck K; Cohen ML
Life Sci; 1994; 54(22):1671-80. PubMed ID: 7909909
[TBL] [Abstract][Full Text] [Related]
35. The pre- and postjunctional activity of CP-122,288, a conformationally restricted analogue of sumatriptan.
Beattie DT; Connor HE
Eur J Pharmacol; 1995 Apr; 276(3):271-6. PubMed ID: 7601213
[TBL] [Abstract][Full Text] [Related]
36. Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation.
Razzaque Z; Heald MA; Pickard JD; Maskell L; Beer MS; Hill RG; Longmore J
Br J Clin Pharmacol; 1999 Jan; 47(1):75-82. PubMed ID: 10073743
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular effects of SL65.0472, a 5-HT receptor antagonist.
O'Connor SE; Grosset A; La Rochelle CD; Gautier E; Bidouard JP; Robineau P; Caille D; Janiak P
Eur J Pharmacol; 2001 Mar; 414(2-3):259-69. PubMed ID: 11239927
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery.
Longmore J; Maguire JJ; MacLeod A; Street L; Schofield WN; Hill RG
Br J Clin Pharmacol; 2000 Feb; 49(2):126-31. PubMed ID: 10671906
[TBL] [Abstract][Full Text] [Related]
39. Differences in the effects of ketanserin and GR127935 on 5-HT-receptor mediated responses in rabbit saphenous vein and guinea-pig jugular vein.
Razzaque Z; Longmore J; Hill RG
Eur J Pharmacol; 1995 Sep; 283(1-3):199-206. PubMed ID: 7498311
[TBL] [Abstract][Full Text] [Related]
40. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
